Smith Serenedy, Marino Ingrid, Schaller Jeanie, Arnell Christopher, Moyes Kelsey, Manley Susan
Myriad Genetic Laboratories, Inc., Salt Lake City, UT, USA.
Per Med. 2017 May;14(3):213-220. doi: 10.2217/pme-2016-0091. Epub 2017 Mar 29.
To evaluate one laboratory's hereditary cancer testing clinical quality assurance (QA) process to minimize test-ordering errors.
The proportion of tests canceled/revised due to pre-analytic QA processes or provider consultation prior to test ordering were determined and the resulting health cost savings were estimated.
Over 2000 genetic test orders were canceled/revised over a 1-year period due to the laboratory QA process, saving US$5,801,832 in healthcare costs. Consultation with healthcare providers prior to submitting genetic test requests resulted in 37 canceled/revised test orders in a 2-week period, which extrapolates to a savings of US$3,049,098 over 1 year.
QA processes can contribute to the curtailment of healthcare costs through canceling or revising test orders.
评估某实验室的遗传性癌症检测临床质量保证（QA）流程，以尽量减少检测订单错误。
确定因分析前QA流程或检测订单下达前与医疗服务提供者协商而取消/修订的检测比例，并估算由此产生的医疗成本节省情况。
在1年时间里，由于实验室QA流程，超过2000份基因检测订单被取消/修订，节省医疗成本5,801,832美元。在提交基因检测申请前与医疗服务提供者进行协商，在2周内导致37份检测订单被取消/修订，按此推算，1年可节省3,049,098美元。
QA流程可通过取消或修订检测订单来减少医疗成本。
